Document Detail

The drugging of the Third World.
MedLine Citation:
PMID:  7141775     Owner:  NLM     Status:  MEDLINE    
This article reports an investigation of the promotion of more than 500 products marketed by over 150 pharmaceutical companies in the United States, Great Britain, Latin America, Africa, and Asia. In contrast to the promotional material provided to physicians in the United States and Great Britain, material presented to physicians in Third World countries was found to be marked by gross exaggeration of product effectiveness and minimized or completely omitted potential hazards. No substantial differences could be found between multinational and domestic companies, brand-name and generic firms, or companies based in capitalist nations and those in socialist or communist-bloc countries in terms of the adequacy and accuracy of their promotion. Little evidence was found to support industry claims that the discrepancies in promotion reflect the different policies of various drug regulatory agencies. Much of the promotion concerned "luxury products," including costly tonics and appetite stimulants marketed in poor countries where the pressing need is for food. Bribery of influential physicians and key governmental officials may play an important role in irrational drug promotion and use in the Third World. Some of the proposed corrective approaches to this problem are examined.
M Silverman; P R Lee; M Lydecker
Related Documents :
7918885 - Consumer responsibility in the hmo environment.
17620045 - Emerging technologies for point-of-care genetic testing.
15966155 - Telehome care--legal advice for telehealth pioneers.
10181895 - Organizational and market determinants of hmos' performance of preventive practices.
16542475 - Multiresistant enterobacter cloacae outbreak in an intensive care unit associated with ...
2146335 - Assessing seizure activity in mentally disabled adults.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  International journal of health services : planning, administration, evaluation     Volume:  12     ISSN:  0020-7314     ISO Abbreviation:  Int J Health Serv     Publication Date:  1982  
Date Detail:
Created Date:  1983-01-19     Completed Date:  1983-01-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1305035     Medline TA:  Int J Health Serv     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  585-96     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Advertising as Topic*
Developing Countries*
Drug Industry / standards*
Drug Labeling / standards*
Ethics, Professional
Legislation, Drug

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Worker participation and autonomy: a multilevel approach to democracy at the workplace.
Next Document:  Inequalities in health and disease: the case of mortality rates for the city of Johannesburg, South ...